Eosinophilia in Patients with Asthma: A Sign of Eosinophilic Granulomatosis with Polyangiitis (EGPA)?

To participate in this activity, please:

Welcome to this video question and answer interview with Michael Wechsler, MD. In this activity, Dr. Wechsler answers common questions physicians have about the diagnosis, prognosis, and treatment of EGPA. This Q&A addresses topics such as the role of ANCA in diagnosis and prognosis, the clinical signs and symptoms of EGPA, clinical features associated with poor prognosis, specialists who may see patients with EGPA presenting as another disorder, and treatment response, escalation, and monitoring.

Want to learn more?

Course Credit:

0.75 AANP Contact Hours
0.75 AMA PRA Category 1 CreditsTM

Dates:

Opens: 2020-06-30
Closes: 2021-06-30

Target Audience:

This activity was developed for allergist/immunologists, rheumatologists, pulmonologists, hematologists, dermatologists, cardiologists, EENT specialists and other clinicians involved in the care of patients with EGPA.

This educational activity is supported by an educational grant from GlaxoSmithKline.
  • Michael E. Wechsler, MD, MMSc

    Professor of Medicine
    Director, Cohen Family NJH Asthma Institute
    Director, Asthma Program, National Jewish Health
    Division of Pulmonary, Critical Care and Sleep Medicine
    Department of Medicine
    National Jewish Health and University of Colorado School of Medicine
    Denver, Colorado